Daniel F. Hayes

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

4in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 4 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Use of comprehensive next-generation sequencing to identify pathogenic germline variants with therapeutic relevance in metastatic breast cancer.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.10527

Top 100%

0DataRank

Top 100%0 citations

Yi‐Mi Wu, Dan R. Robinson, James M. Rae, N. Lynn Henry, Daniel F. Hayes +9 more

Papers

Driven by 28 papers — median percentile 0. Top paper: “Patient-Reported Cognitive Impairment Among Women With Early Breast Cancer Randomly Assigned to Endocrine Therapy Alone Versus Chemoendocrine Therapy: Results From TAILORx”.

Patient-Reported Cognitive Impairment Among Women With Early Breast Cancer Randomly Assigned to Endocrine Therapy Alone Versus Chemoendocrine Therapy: Results From TAILORx

Journal of Clinical Oncology(2020)10.1200/jco.19.01866

N/A

3.5DataRank · unranked

102 citations

Robert J. Gray, Joseph A. Sparano, Timothy J. Whelan, Sofia F. Garcia, Betina R. Yanez +14 more

Cisplatin with veliparib or placebo in metastatic triple-negative breast cancer and BRCA mutation-associated breast cancer (S1416): a randomised, double-blind, placebo-controlled, phase 2 trial

The Lancet Oncology(2023)10.1016/s1470-2045(22)00739-2

N/A

2.0DataRank · unranked

102 citations

Priyanka Sharma, William E. Barlow, Julie R. Gralow, Shannon L. Puhalla, Carey K. Anders +16 more

Assessment of Ki67 in Breast Cancer: Updated Recommendations From the International Ki67 in Breast Cancer Working Group

JNCI Journal of the National Cancer Institute(2020)10.1093/jnci/djaa201

N/A

0.995DataRank · unranked

757 citations

Samuel Leung, David L. Rimm, Andrew Dodson, Balázs Ács, Sunil Badve +17 more

Discovery of ERD-308 as a Highly Potent Proteolysis Targeting Chimera (PROTAC) Degrader of Estrogen Receptor (ER)

Journal of Medicinal Chemistry(2019)10.1021/acs.jmedchem.8b01572

N/A

0.844DataRank · unranked

276 citations

Biao Hu, Mingliang Wang, Fuming Xu, Bukeyan Miao, Chao-Yie Yang +8 more

Assessment of Clinical Benefit of Integrative Genomic Profiling in Advanced Solid Tumors

JAMA Oncology(2021)10.1001/jamaoncol.2020.7987

N/A

0.761DataRank · unranked

159 citations

Yi-Mi Wu, Pankaj Vats, Rashmi Chugh, Francis Worden, David C. Smith +25 more

Overall Survival with Fulvestrant plus Anastrozole in Metastatic Breast Cancer

New England Journal of Medicine(2019)10.1056/nejmoa1811714

N/A

0.729DataRank · unranked

128 citations

William E. Barlow, Kathy S. Albain, Ted A. Vandenberg, Shaker R. Dakhil, Nagendra R. Tirumali +7 more

Race, Ethnicity, and Clinical Outcomes in Hormone Receptor-Positive, HER2-Negative, Node-Negative Breast Cancer in the Randomized TAILORx Trial

JNCI Journal of the National Cancer Institute(2020)10.1093/jnci/djaa148

N/A

0.714DataRank · unranked

116 citations

Robert J. Gray, Della Makower, Amir Faghih, Daniel F. Hayes, Charles E. Geyer +23 more

Thymidine kinase activity levels in serum can identify HR+ metastatic breast cancer patients with a low risk of early progression (SWOG S0226)

Biomarkers(2023)10.1080/1354750x.2023.2168063

N/A

0.587DataRank · unranked

12 citations

Adrian Nordmark, Amy Williams, Costanza Paoletti, William E. Barlow, Erin F. Cobain +11 more

Results of a phase II randomized trial of cisplatin +/- veliparib in metastatic triple-negative breast cancer (TNBC) and/or germline BRCA-associated breast cancer (SWOG S1416).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.1001

N/A

0.587DataRank · unranked

49 citations

Eve T. Rodler, William E. Barlow, Julie R. Gralow, Shannon Leigh Huggins-Puhalla, Carey K. Anders +15 more

Evaluating Serum Thymidine Kinase 1 in Patients with Hormone Receptor–Positive Metastatic Breast Cancer Receiving First-line Endocrine Therapy in the SWOG S0226 Trial

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-21-1562

N/A

0.457DataRank · unranked

20 citations

William E. Barlow, Erin F. Cobain, Mattias Bergqvist, Rita S. Mehta, Julie R. Gralow +9 more

Race and clinical outcomes in hormone receptor-positive, HER2-negative, node-positive breast cancer in the randomized RxPONDER trial

JNCI Journal of the National Cancer Institute(2024)10.1093/jnci/djae314

N/A

0.443DataRank · unranked

10 citations

William E. Barlow, Julie R. Gralow, Funda Meric‐Bernstam, Kathy S. Albain, Daniel F. Hayes +19 more

Prospective Validation of a 21-Gene Expression Assay in Breast Cancer

Digital Commons@Becker (Washington University School of Medicine)(2020)10.17615/6e7v-pv95

N/A

0.104DataRank · unranked

1 citations

Tracy Lively, John A. Olson, Robert J. Gray, Virginia Kaklamani, Della Makower +26 more

Muscle mass affects paclitaxel systemic exposure and may inform personalized paclitaxel dosing

British Journal of Clinical Pharmacology(2022)10.1111/bcp.15244

N/A

0DataRank · unranked

18 citations

Li Chen, N. Lynn Henry, Jennifer J. Griggs, Daniel F. Hayes, Brian A. Derstine +4 more

Genome-wide association study of aromatase inhibitor discontinuation due to musculoskeletal symptoms

Research Square(2022)10.21203/rs.3.rs-1315678/v1

N/A

0DataRank · unranked

5 citations

Julie A. Douglas, Robert M. Miller, Kelley M. Kidwell, Christina L. Gersch, Zeruesenay Desta +7 more

Polypharmacy and premature aromatase inhibitor (AI) discontinuation in older women with breast cancer.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.6568

N/A

0DataRank · unranked

0 citations

Kelley M. Kidwell, Vered Stearns, Daniel F. Hayes, Anna Maria Storniolo, N. Lynn Henry +1 more

Genetic Variation in Charcot–Marie–Tooth Genes Contributes to Sensitivity to Paclitaxel-Induced Peripheral Neuropathy

Pharmacogenomics(2020)10.2217/pgs-2020-0053

N/A

0DataRank · unranked

14 citations

Fang Fang, Kelley M. Kidwell, Kiran Vangipuram, Lauren A. Marcath, Christina L. Gersch +7 more

Novel Prognostic Staging System for Patients With De Novo Metastatic Breast Cancer

Journal of Clinical Oncology(2023)10.1200/jco.22.02222

N/A

0DataRank · unranked

42 citations

Samantha M. Thomas, Daniel F. Hayes, Mariana Chávez‐MacGregor, Kimberly H. Allison, Jennifer De Los Santos +8 more

Use of comprehensive next-generation sequencing to identify pathogenic germline variants with therapeutic relevance in metastatic breast cancer.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.10527

Top 100%

0DataRank

Top 100%0 citations

Yi‐Mi Wu, Dan R. Robinson, James M. Rae, N. Lynn Henry, Daniel F. Hayes +9 more

Optimizing Precision Medicine for Breast Cancer Brain Metastases with Functional Drug Response Assessment

Cancer Research Communications(2023)10.1158/2767-9764.crc-22-0492

N/A

0DataRank · unranked

5 citations

Jinju Li, Peter Ulintz, Xu Cheng, Athena Apfel, Dan R. Robinson +14 more

Data from Evaluating Serum Thymidine Kinase 1 in Patients with Hormone Receptor–Positive Metastatic Breast Cancer Receiving First-line Endocrine Therapy in the SWOG S0226 Trial

(2023)10.1158/1078-0432.c.6530384.v1

N/A

0DataRank · unranked

0 citations

William E. Barlow, Erin F. Cobain, Mattias Bergqvist, Rita S. Mehta, Julie R. Gralow +9 more

Data from Evaluating Serum Thymidine Kinase 1 in Patients with Hormone Receptor–Positive Metastatic Breast Cancer Receiving First-line Endocrine Therapy in the SWOG S0226 Trial

(2023)10.1158/1078-0432.c.6530384

N/A

0DataRank · unranked

0 citations

William E. Barlow, Erin F. Cobain, Mattias Bergqvist, Rita S. Mehta, Julie R. Gralow +9 more

Data from Association of Variants in Candidate Genes with Lipid Profiles in Women with Early Breast Cancer on Adjuvant Aromatase Inhibitor Therapy

(2023)10.1158/1078-0432.c.6523959

N/A

0DataRank · unranked

0 citations

Amanda L. Blackford, Anne Nguyen, Todd C. Skaar, Santosh Philips, Steffi Oesterreich +12 more

Comparing the prognostic and predictive utility of serum thymidine kinase 1 and CA 15-3 in patients with hormone receptor positive metastatic breast cancer starting first-line endocrine therapy in SWOG S0226.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.1076

N/A

0DataRank · unranked

0 citations

William E. Barlow, Costanza Paoletti, Mattias Bergqvist, Amy Williams, Hanna Ritzén +11 more

Serial monitoring of genomic alterations in circulating tumor cells of ER‐positive/HER2‐negative advanced breast cancer: feasibility of precision oncology biomarker detection

Molecular Oncology(2021)10.1002/1878-0261.13150

N/A

0DataRank · unranked

21 citations

Emily M. Dolce, Elizabeth P. Darga, Kevin Hu, Chia‐Jen Liu, Jackie Pierce +27 more

Race and Clinical Outcomes in Hormone Receptor-Positive, HER2-Negative, Node-Positive Breast Cancer in the Randomized RxPONDER Trial

UNC Libraries(2025)10.17615/dgtt-ap31

N/A

0DataRank · unranked

0 citations

Julie R. Gralow, Edith Perez, Kevin Kalinsky, Gabriel N. Hortobágyi, Nancy U. Lin +19 more

Inertial focusing of circulating tumor cells in whole blood at high flow rates using the microfluidic CTCKey™ device for CTC enrichment

Lab on a Chip(2021)10.1039/d1lc00546d

N/A

0DataRank · unranked

36 citations

Jessica Antoinette Jana, Anna Kaehr, Emma Purcell, Tyler Opdycke, Costanza Paoletti +5 more

Association Between 21-Gene Assay Recurrence Score and Locoregional Recurrence Rates in Patients With Node-Positive Breast Cancer

JAMA Oncology(2020)10.1001/jamaoncol.2019.5559

N/A

0DataRank · unranked

78 citations

William E. Barlow, Reshma Jagsi, Thomas A. Buchholz, Steven Shak, Frederick L. Baehner +13 more

p53 Expression in Node-Positive Breast Cancer Patients: Results from the Cancer and Leukemia Group B 9344 Trial (159905)

UNC Libraries(2020)10.17615/n42e-6c96

N/A

0DataRank · unranked

0 citations

Lynn G. Dressler, Donald A. Berry, Lori J. Goldstein, Gloria Broadwater, Susan M. Edgerton +12 more

Daniel F. Hayes

Indexed papers

Top data-sharing exemplar

Papers